← All trials
NCT04319614
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 24, 2020
- Primary completion
- Dec 31, 2021
- Completion date
- Mar 30, 2022
- First posted
- Mar 24, 2020
- Last posted
- Mar 27, 2020
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University Hospital Hradec KraloveLead sponsor
- University Hospital Hradec KraloveOverall official - principal investigator
- University Hospital Hradec KraloveStudy chair
- University Hospital Hradec KraloveReponsible party - principal investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.